However, a positive association of FABP-4 and CRC risk in women was observed in the biomarker analysis before adjustment for body size, suggesting that the positive association was largely explained by the upregulation of FABP-4 in obesity [7]. This evidence concerns the gene FABP4 and colorectal carcinoma.